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The transcription factor cAMP response element modu-
lator (CREM) is a widely expressed transcriptional
repressor which is important for the termination of the
T cell immune response. CREMa is overexpressed in
SLE (Systemic lupus erythematosus) T cells and is sup-
posed to be a key player in orchestrating the transcrip-
tional program of SLE T cells by targeting T cell-relevant
genes. To explore the relevance of CREMa in vivo we
used a well-established murine lupus model, which is
characterized by the introduction of a mutation in the
CD95 (Fas) locus. We generated a transgenic mouse with
a selective overexpression of CREMa in T cells and
introduced a Fas -/- phenotype into the CREMa trans-
genic mice. CREMa transgenic Fas -/- mice developed a
severe lymphadenopathy and splenomegaly as early as
8 weeks of age, while the wildytpe Fas -/- mice did not at
this early age. Lymphadenopathy and splenomegaly is
paralleled by a massive expansion of pathogenic CD3
+CD4-CD8- double negative T cells. Furthermore T cells
of CREMa transgenic Fas -/- mice show an enhanced
production of IL-21 and IL-17, which are hallmark cyto-
kines of highly inflammatory Th17 cells. Vice versa per-
centages of regulatory T cells are reduced. The enhanced
occurrence of aberrant and inflammatory T cells further
leads to increased B cell activation, increased anti-DNA
antibody titers and finally shortened life expectation of
these mice.
Our experiments are the proof of principle for a criti-
cal amplifying role of CREMa in autoimmune prone
conditions like SLE.
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